Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 27;15(7):e42563.
doi: 10.7759/cureus.42563. eCollection 2023 Jul.

Impact of COVID-19 Pandemic on Respiratory Syncytial Virus (RSV) Prophylaxis Program: A Tertiary-Care Center Experience

Hamza M Kelabi  1 , Adel S Alharbi  1 , Abdullah S Alshamrani  1 , Khaled Baqais  1 , Ayed M Alenazi  1 , Mansour M Alqwaiee  1
Affiliations

Impact of COVID-19 Pandemic on Respiratory Syncytial Virus (RSV) Prophylaxis Program: A Tertiary-Care Center Experience

Hamza M Kelabi et al. Cureus. .

Abstract

Objectives: The purpose of this investigation was to evaluate the effects of the COVID-19 pandemic on the respiratory syncytial virus (RSV) prevention program at our institution across three time frames: 2019-2020, 2020-2021, and 2021-2022.

Methods: We carried out a descriptive, single-site observational study spanning four years, from June 2019 to June 2022. Our study included patients in our institution's RSV program who met our enrollment criteria. We collected information about the number of children receiving immunoprophylaxis, immunoprophylaxis doses, and RSV risk factors.

Results: The number of patients receiving immunoprophylaxis dropped across the three periods, from 315 patients in the first period (2019-2020) to 176 in the second period (2020-2021), and further decreased to 128 in the third period (2021-2022). Following the COVID-19 pandemic, there was a 50% reduction in the number of patients receiving immunoprophylaxis. The proportion of RSV-infected patients remained relatively similar in the first and second periods (2.86% and 2.27%, respectively) but increased in the third period (5.47%). In the first period, most patients (60.32%) received seven doses, 11.75% got four to six doses, and 27.95% received three doses or fewer. The second period saw 59.66% of patients receiving four to six doses and 40.34% receiving three doses or fewer. In the third period, a mere 9.38% received four to five doses, while 90.63% got three doses or fewer.

Conclusions: While preventative measures associated with COVID-19 may have helped reduce the number of RSV cases, the pandemic seems to have caused a significant decrease in the number of children receiving immunoprophylaxis and the doses of immunoprophylaxis. More extensive, multicenter research is needed to understand the impact of the COVID-19 pandemic on RSV immunoprophylaxis, its activity, and seasonal patterns fully.

Keywords: covid-19; pediatrics; prophylaxis; rsv; saudi arabia.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Risk factors of RSV
RSV: respiratory syncytial virus, CHD: congenital heart disease
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Respiratory syncytial virus infection and bronchiolitis. Piedimonte G, Perez MK. Pediatr Rev. 2014;35:519–530. - PMC - PubMed
    1. Viral etiology of respiratory infections in children in southwestern Saudi Arabia using multiplex reverse-transcriptase polymerase chain reaction. Al-Ayed MS, Asaad AM, Qureshi MA, Ameen MS. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362149/ Saudi Med J. 2014;35:1348–1353. - PMC - PubMed
    1. Lower respiratory tract infections among Saudi children: a review of literature. Mohamed H, Alanazi IM, Alfeheid FH, et al. https://eijppr.com/storage/models/article/F5B1uMZIP2KOKBFZe6yecSfnWiIHgi... Int J Pharm Phytopharmacological Res. 2020;10:53–59.
    1. WHO strategy to pilot global respiratory syncytial virus surveillance based on the Global Influenza Surveillance and Response System (‎GISRS)‎. [ Feb; 2022 ];https://apps.who.int/iris/handle/10665/259853 THE. 2017 1:60.
    1. Bronchiolitis in children: the Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO) Alharbi AS, Alqwaiee M, Al-Hindi MY, et al. Ann Thorac Med. 2018;13:127–143. - PMC - PubMed

LinkOut - more resources